Careverse CoronaryDoc (Careverse CoronaryDoc)
Overview
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool designed to automatically identify coronary arteries, detect stenosis, and characterize plaques. It delivers fast, accurate, and reproducible results, supporting clinical decision-making, enhancing workflow efficiency, and enabling early intervention in coronary artery disease across cardiology and radiology departments. The AI-driven algorithms for 3D reconstruction and segmentation allow clinicians to complete the post-processing workflow with minimal manual intervention in just three minutes. This facilitates the visualization and analysis of coronary CT angiography images, enabling precise assessment of coronary artery stenosis in patients with coronary artery disease, as well as accurate identification of atherosclerotic plaques, stents, and myocardial bridges. For precise diagnosis, Careverse CoronaryDoc revolutionizes the traditional radiology workflow by enabling fully automated vessel segmentation and image reconstruction, eliminating time-consuming post-processing and multi-step handoffs, with the entire process completed in as little as one minute.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered coronary CTA analysis
- Automatic identification of coronary arteries
- Detection of stenosis with over 90% accuracy
- Characterization of plaques
- Fast, accurate, and reproducible results
- 3D reconstruction and segmentation of coronary arteries
- Minimal manual intervention for post-processing
- Fully automated vessel segmentation and image reconstruction
- Handles complex clinical scenarios including bypasses, stents, myocardial bridges, and ectopic origins
- Integration with CT-FFR for functional analysis of coronary arteries
Use Cases
- Supporting clinical decision-making in cardiology and radiology departments
- Enhancing workflow efficiency in medical imaging
- Enabling early intervention in coronary artery disease
- Precise assessment of coronary artery stenosis
- Accurate identification of atherosclerotic plaques, stents, and myocardial bridges
- Assisting in generating diagnostic suggestions and pre-reports
What Physicians Need to Know
Careverse CoronaryDoc serves as a 'Healthcare Copilot' by significantly reducing the manual workload for radiologists and cardiologists, allowing more time for accurate diagnoses and inter-departmental collaboration. It delivers fast, accurate, and reproducible results, supporting clinical decision-making and enabling early intervention in coronary artery disease. Physicians can leverage its fully automated CT-FFR product for objective and convenient functional assessment of coronary artery stenosis. While the tool automates many processes, it is crucial for medical professionals to always verify the product's extraction results. The system also assists with structured clinical documentation and can provide clinical reasoning analysis based on integrated medical literature and guidelines.
Careverse CoronaryDoc is designed for seamless integration into existing clinical workflows, with Careverse solutions already adopted by thousands of hospitals globally. The platform offers one-stop image visualization, facilitating collaboration between radiologists and cardiologists. It operates as a web-based software application, and localized deployment within the hospital intranet ensures data privacy.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Localized deployment within the hospital intranet, ensuring data privacy within the hospital. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated Careverse CoronaryDoc has received FDA 510(k) clearance (K251656). Careverse Technology also holds 2 FDA 510(K) approvals for other AI products, including Head and Neck CTA and CTP AI. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
What the Web Says
Careverse CoronaryDoc is an AI-powered software designed to assist clinicians in analyzing coronary computed tomography angiography (CCTA) images more efficiently and accurately. It automates the identification of coronary arteries, detection of stenosis, and characterization of plaques, aiming to enhance workflow efficiency and support clinical decision-making for early intervention in coronary artery disease. The software has received FDA approval and CE Mark certification, and has been showcased at major radiology congresses.
Overall: PositiveStrengths
- Automated vessel segmentation and image reconstruction, significantly reducing post-processing time to as little as one minute.
- Provides fast, accurate, and reproducible results for coronary CTA analysis.
- Supports clinical decision-making and enables early intervention in coronary artery disease.
- Capable of handling complex clinical scenarios such as bypasses, stents, myocardial bridges, and ectopic origins.
- Offers fully automated coronary CAD-RADs and CT-FFR analysis, from image post-processing to reporting, in approximately three minutes.
- Improves diagnostic accuracy compared to cCTA and can optimize patient management.
Limitations
- No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra regarding Careverse CoronaryDoc.
- General challenges with patient engagement software include adoption, integrations with existing health systems, and compliance with healthcare regulations.
- Some general AI capabilities in other healthcare software have been noted to need work in terms of process time and wording.
Based on reviews from: Careverse Technology Pte. Ltd., KLN Medical, Careverse, Irudigi, G2, Capterra
Last updated: 2026-07-17
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Careverse CoronaryDoc (Careverse CoronaryDoc)
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Careverse CoronaryDoc (Careverse CoronaryDoc).
No videos found. Search YouTube directly





